News & Events
![Ventoux Biosciences Biopharmaceutical Company of the Year](https://www.ventouxbio.com/wp-content/uploads/2024/04/Global-24-Winner-53.png)
Biopharmaceutical Company of the Year
Ventoux Biosciences Recognized as Biopharmaceutical Company of the Year We are honored and excited to share that Ventoux Biosciences has received the award for Biopharmaceutical
![Dupuytren's Disease](https://www.ventouxbio.com/wp-content/uploads/2024/04/Dupuytren-syndrome-hand-website.webp)
Biosciences Innovator Launches Fundraising Round After Successful Pre-Clinical Results for Fibrosis Treatment
Dupuytren’s is a common, progressive, debilitating fibrosis of the hands. Ventoux Biosciences is on a mission to develop new treatment options.
![Dupuytren's disease focused company with positive mouse model data](https://www.ventouxbio.com/wp-content/uploads/2024/03/Untitled-26.png)
A founder’s quest for a drug to treat his own hand condition kicks off with positive mouse data
The surgeons who treat it call it “the most common crippling hand disease you’ve never heard of”: Dupuytren’s contracture, an incurable, sometimes painful disorder where cords of fibrotic
![](https://www.ventouxbio.com/wp-content/uploads/2024/03/Pipeline-Website-Image.png)
Ventoux Biosciences Announces Positive Pre-Clinical Results, Initiates Fundraising Round to Advance Development
Ventoux Biosciences, Founded by Dupuytren’s Patient, Announces Positive Anti-Fibrotic Effects with VEN-201 and Initiates Initial Fundraising Round ENCINITAS, CALIFORNIA, UNITED STATES, March 12, 2024 /EINPresswire.com/
![](https://www.ventouxbio.com/wp-content/uploads/2024/06/HoC-Podcast-Episode-1-Dad-copy-1.jpeg)
Episode 1 | Hands of Change Podcast
In this episode of “Hands of Change” – Retired Airline Captain Woody Harrington, and father of host Kurt Harrington, share’s his experiences of living with
![Hands of Change Podcast Cover Image](https://www.ventouxbio.com/wp-content/uploads/2024/03/HoC-Podcast-Resize.png)
Hands of Change Podcast
Hands of Change is a new podcast dedicated to Dupuytren’s disease and related conditions. Hosted by Kurt Harrington and supported by Ventoux Biosciences, the show